Journals / Acta Orthopaedica et Traumatologica Turcica / 2016 / Cilt: 50 - Sayı: 6

Modular cementless prosthetic reconstruction after resection of lower extremity malignant tumor

Pages
674–680
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Mean overall Musculoskeletal Tumor Society score scorewas 72.7 percent (range, 52 to 86).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: The aim of the study is to report the preliminary clinical and functional outcomes of amodular cementless tumor resection prosthesis system (Megasystem-C®, Waldemar Link GmbH&Co.
📊
Key Findings & Data:KG,Hamburg, Germany) in patients undergoing limb salvage surgery with wide resection in a lower extremity primary or metastatic malignant bone tumor.Material and methods: Fifty-two consecutive patients (33 male and 19 female; mean age 37.1 years(range, 16 to 79) with primary or metastatic lower extremity malignant bone tumor who underwentwide resection and reconstruction with cementless Megasystem-C®system were included in the study.Patients were analyzed for age at diagnosis, gender, type and localization of the tumor, time of follow-up,patient and prosthesis survival, complications, oncological and functional outcomes.Results: Mean follow-up time was 43.2 months (range, 8 to 66).
💡
Conclusion & Impact:Mean overall Musculoskeletal Tumor Society score scorewas 72.7 percent (range, 52 to 86).
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: The aim of the study is to report the preliminary clinical and functional outcomes of amodular cementless tumor resection prosthesis system (Megasystem-C®, Waldemar Link GmbH&Co. KG,Hamburg, Germany) in patients undergoing limb salvage surgery with wide resection in a lower extremity primary or metastatic malignant bone tumor.Material and methods: Fifty-two consecutive patients (33 male and 19 female; mean age 37.1 years(range, 16 to 79) with primary or metastatic lower extremity malignant bone tumor who underwentwide resection and reconstruction with cementless Megasystem-C®system were included in the study.Patients were analyzed for age at diagnosis, gender, type and localization of the tumor, time of follow-up,patient and prosthesis survival, complications, oncological and functional outcomes.Results: Mean follow-up time was 43.2 months (range, 8 to 66). Cumulative patient survival rate was92.3 percent and cumulative prosthetic survival rate was 65.4 percent. 18 complications were recordedand 9 of them required revision (17.3 percent). Mean overall Musculoskeletal Tumor Society score scorewas 72.7 percent (range, 52 to 86). Subgroup analyzes demonstrated no difference in complication rates,overall patient or prosthetic survivals. Functional scores according to age, diagnosis and location of thereconstruction also were not signiŞcantly different.Conclusion: The preliminary short-term follow-up results revealed that, the new generation modularcementless endoprosthetic system offers promising clinical and functional outcomes with reasonablecomplication rates.Level of evidence: Level IV, Therapeutic study

🔖

Cite This Article

BEKMEZ, Ş., AYVAZ, M., YUCEKUL, A., TOKGÖZOĞLU, A. M. (2016). Modular cementless prosthetic reconstruction after resection of lower extremity malignant tumor. Acta Orthopaedica et Traumatologica Turcica, Cilt: 50 - Sayı: 6, 674–680. https://ajindex.com/articles/202459

References (13)

  1. Bacci G, Picci P, Ferrari S, et al. Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin. Cancer. 1993;72:3227e3238
  2. Link MP, Goorin AM, Miser AW, et al. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med. 1986;314:1600e1606
  3. Rougraff BT, Simon MA, Greenberg DB, Mankin HJ. Limb salvage compared with amputation for osteosarcoma of the distal end of the femur. A long-term oncological, functional, and quality-of-life study. J Bone Jt Surg Am. 1994;76: 649e656
  4. Simon MA, Aschliman MA, Thomas N, Mankin HJ. Limb-salvage treatment versus amputation for osteosarcoma of the distal end of the femur. J Bone Jt Surg Am. 1986;68:1331e1337
  5. Mavrogenis AF, Abati CN, Romagnoli C, Ruggieri P. Similar survival but better function for patients after limb salvage versus amputation for distal tibia osteosarcoma. Clin Orthop Relat Res. 2012 Jun;470(6):1735e1748
  6. Harris JE, Left AR, Gitelis S, Simon MA. Function after amputation, arthodesis or arthrplasty for tumors about the knee. J Bone Jt Surg. 1990;72A: 1477e1485
  7. Horowitz S, Glasser D, Lane J, Healey J. Prosthetic and extremity survivorship in limb salvage: how long do the reconstructions last? Clin Orthop Relat Res. 1993;293:280
  8. Khattak MJ, Umer M, Haroon-ur-Rasheed, Umar M. Autoclaved tumor bone for reconstruction: an alternative in developing countries. Clin Orthop Relat Res. 2006;447:138e144
  9. Farid Y, Lin PP, Lewis VO, Yasko AW. Endoprosthetic and allograft-prosthetic composite reconstruction of the proximal femur for bone neoplasms. Clin Orthop Relat Res. 2006;442:223e229
  10. Malawer MM, Chou LB. Prosthetic survival and clinical results with use of large-segment replacements in the treatment of high-grade bone sarcomas. J Bone Jt Surg Am. 1995;77A:1154e1165
  11. Roberts P, Chan D, Gimer RJ, Sneath RS, Scales JT. Prosthetic replacement of the distal femur for primary bone tumours. J Bone Jt Surg Br. 1991;73B:762
  12. Zeegen EN, Aponte-Tinao LA, Hornicek FJ, Gebhardt MC, Mankin HJ. Survivorship analysis of 141 modular metallic endoprostheses at early followup. Clin Orthop Relat Res. 2004;420:239e250
  13. Guo W, Ji T, Yang R, Tang X, Yang Y. Endoprosthetic replacement for primary tumours around the knee: experience from Peking University. J Bone Jt Surg Br. 2008;90:1084e